These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-immunoglobulin E therapy with omalizumab for asthma. Hendeles L, Sorkness CA. Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897 [Abstract] [Full Text] [Related]
8. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma]. Michils A, Sternon J. J Pharm Belg; 2006 Apr 25; 61(3):83-7. PubMed ID: 17058881 [Abstract] [Full Text] [Related]
9. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma]. Targowski T, From S. Pol Merkur Lekarski; 2003 Jan 25; 14(79):65-8. PubMed ID: 12712834 [Abstract] [Full Text] [Related]
11. [Pneumology. Anti-IgE antibodies in the treatment of asthma]. Leuenberger P, Sauty A, Rochat T. Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662 [Abstract] [Full Text] [Related]
12. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma. Liebhaber M, Dyer Z. J Asthma; 2007 Apr 10; 44(3):195-6. PubMed ID: 17454337 [No Abstract] [Full Text] [Related]
13. Novel and emerging therapies for asthma. Leath TM, Singla M, Peters SP. Drug Discov Today; 2005 Dec 10; 10(23-24):1647-55. PubMed ID: 16376825 [Abstract] [Full Text] [Related]
14. [The future of asthma therapy]. Solèr M. Schweiz Med Wochenschr; 2000 Feb 26; 130(8):277-81. PubMed ID: 10726286 [Abstract] [Full Text] [Related]